These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

61 related articles for article (PubMed ID: 3485846)

  • 21. Periplocoside E, an effective compound from Periploca sepium Bge, inhibited T cell activation in vitro and in vivo.
    Zhu YN; Zhao WM; Yang YF; Liu QF; Zhou Y; Tian J; Ni J; Fu YF; Zhong XG; Tang W; Zhou R; He PL; Li XY; Zuo JP
    J Pharmacol Exp Ther; 2006 Feb; 316(2):662-9. PubMed ID: 16204471
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Cyclosporine A: a tool for analyzing the function of class I MHC antigen-reactive T cells in vivo.
    Hodgkin PD; Dixon JE; Andrus L; Lafferty KJ
    Transplant Proc; 1984 Aug; 16(4):968-9. PubMed ID: 6611620
    [No Abstract]   [Full Text] [Related]  

  • 23. Heterosubtypic immunity to influenza type A virus in mice. Effector mechanisms and their longevity.
    Liang S; Mozdzanowska K; Palladino G; Gerhard W
    J Immunol; 1994 Feb; 152(4):1653-61. PubMed ID: 8120375
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Surface glycoproteins of influenza virus increase cell-mediated immunity functions in mice.
    Del Gobbo V; Villani N; Balestra E; Marini S; Firriolo A; Caliò R
    Boll Ist Sieroter Milan; 1987; 66(1):1-8. PubMed ID: 3497649
    [TBL] [Abstract][Full Text] [Related]  

  • 25. CD27 is required for generation and long-term maintenance of T cell immunity.
    Hendriks J; Gravestein LA; Tesselaar K; van Lier RA; Schumacher TN; Borst J
    Nat Immunol; 2000 Nov; 1(5):433-40. PubMed ID: 11062504
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Pulmonary immune response of young and aged mice after influenza challenge.
    Bender BS; Taylor SF; Zander DS; Cottey R
    J Lab Clin Med; 1995 Aug; 126(2):169-77. PubMed ID: 7636390
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Inhibition of the T suppressor circuit of delayed-type hypersensitivity by interferon.
    Knop J; Stremmer R; Taborski U; Freitag W; de Maeyer-Guignard J; Macher E
    J Immunol; 1984 Nov; 133(5):2412-6. PubMed ID: 6237149
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Analysis of in vivo regulatory properties of T cells activated in vitro by TGFbeta2-treated antigen presenting cells.
    Kezuka T; Streilein JW
    Invest Ophthalmol Vis Sci; 2000 May; 41(6):1410-21. PubMed ID: 10798657
    [TBL] [Abstract][Full Text] [Related]  

  • 29. CC chemokine receptor 7 expression by effector/memory CD4+ T cells depends on antigen specificity and tissue localization during influenza A virus infection.
    Debes GF; Bonhagen K; Wolff T; Kretschmer U; Krautwald S; Kamradt T; Hamann A
    J Virol; 2004 Jul; 78(14):7528-35. PubMed ID: 15220427
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Influence of 2'-deoxyguanosine upon the development of DTH effector T cells and suppressor T cells in vivo.
    Bril H; van den Akker TW; Molendijk-Lok BD; Bianchi AT; Benner R
    J Immunol; 1984 Feb; 132(2):599-604. PubMed ID: 6228591
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Differential effects of the immunosuppressive agents cyclosporine and leflunomide in vivo. Leflunomide blocks clonal T cell expansion yet allows production of lymphokines and manifestation of T cell-mediated shock.
    Lang R; Wagner H; Heeg K
    Transplantation; 1995 Feb; 59(3):382-9. PubMed ID: 7871569
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Local IL-4 expression in the lung reduces pulmonary influenza-virus-specific secondary cytotoxic T cell responses.
    Bot A; Holz A; Christen U; Wolfe T; Temann A; Flavell R; von Herrath M
    Virology; 2000 Mar; 269(1):66-77. PubMed ID: 10725199
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Cell-mediated immunity in herpes simplex virus-infected mice: H-2 mapping of the delayed-type hypersensitivity response and the antiviral T cell response.
    Nash AA; Phelan J; Wildy P
    J Immunol; 1981 Apr; 126(4):1260-2. PubMed ID: 6259256
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Viral peptide specific induction of MHC class II expression by murine T cell clones.
    Thomas DB; Smith CA; Graham CM
    J Immunol; 1996 Sep; 157(6):2386-94. PubMed ID: 8805637
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Immunologic regulation of experimental cutaneous leishmaniasis. V. Characterization of effector and specific suppressor T cells.
    Liew FY; Hale C; Howard JG
    J Immunol; 1982 Apr; 128(4):1917-22. PubMed ID: 6120976
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Role of tumor necrosis factor-related apoptosis-inducing ligand in immune response to influenza virus infection in mice.
    Ishikawa E; Nakazawa M; Yoshinari M; Minami M
    J Virol; 2005 Jun; 79(12):7658-63. PubMed ID: 15919918
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Differential effects of cyclosporin A on the alloreactivity of fresh and ex vivo-expanded T lymphocytes.
    Contassot E; Robinet E; Angonin R; Laithier V; Bittencourt M; Pavy JJ; Cahn JY; Hervé P; Tiberghien P
    Bone Marrow Transplant; 1998 Dec; 22(11):1097-102. PubMed ID: 9877273
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Immunopharmacology of cyclosporin A].
    Nikitin AV
    Antibiot Med Biotekhnol; 1986 Jan; 31(1):56-66. PubMed ID: 2418777
    [No Abstract]   [Full Text] [Related]  

  • 39. Cyclosporin A plus fish oil: accentuate the positive, eliminate the negative.
    Kelley VE; Mackie J; Strom TB
    Transplant Proc; 1989 Feb; 21(1 Pt 1):848-9. PubMed ID: 2705249
    [No Abstract]   [Full Text] [Related]  

  • 40. In vivo cyclosporine A treatment inhibits spleen cell mitogen-triggered free [Ca2+] increase.
    Chatenoud L; Dugas B; Damais C; Bach JF
    Transplant Proc; 1988 Apr; 20(2 Suppl 2):170-2. PubMed ID: 3363638
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.